Topics

FDA grants Orphan Drug status to nomacopan for bullous pemphigoid

05:34 EDT 16 Sep 2019 | SmartBrief

Akari Therapeutics' nomacopan, a treatment for bullous pemphigoid, was granted Orphan Drug Designation by the FDA. -More

Original Article: FDA grants Orphan Drug status to nomacopan for bullous pemphigoid

NEXT ARTICLE

More From BioPortfolio on "FDA grants Orphan Drug status to nomacopan for bullous pemphigoid"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...